Panagora Asset Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-25,879
| Closed | -$2.2M | – | 2697 |
|
|
2019
Q4 | $2.2M | Sell |
25,879
-545,834
| -95% | -$36.4M | 0.01% | 752 |
|
|
2019
Q3 | $28.6M | Sell |
571,713
-14,898
| -3% | -$594K | 0.13% | 159 |
|
|
2019
Q2 | $21.4M | Buy |
586,611
+130,607
| +29% | +$4.26M | 0.1% | 209 |
|
|
2019
Q1 | $12.7M | Buy |
456,004
+282,587
| +163% | +$6.66M | 0.06% | 307 |
|
|
2018
Q4 | $3.32M | Sell |
173,417
-55,976
| -24% | -$1.3M | 0.02% | 590 |
|
|
2018
Q3 | $6.86M | Buy |
229,393
+54,087
| +31% | +$2.04M | 0.03% | 443 |
|
|
2018
Q2 | $6.43M | Sell |
175,306
-186,247
| -52% | -$6.05M | 0.03% | 465 |
|
|
2018
Q1 | $11.9M | Sell |
361,553
-82
| -0% | -$2.56K | 0.05% | 322 |
|
|
2017
Q4 | $9.89M | Sell |
361,635
-18,885
| -5% | -$582K | 0.04% | 391 |
|
|
2017
Q3 | $14.1M | Sell |
380,520
-6,861
| -2% | -$253K | 0.06% | 322 |
|
|
2017
Q2 | $14.7M | Sell |
387,381
-110,873
| -22% | -$4.94M | 0.06% | 312 |
|
|
2017
Q1 | $24.4M | Buy |
498,254
+25,401
| +5% | +$1.16M | 0.1% | 220 |
|
|
2016
Q4 | $16M | Sell |
472,853
-9,605
| -2% | -$341K | 0.07% | 274 |
|
|
2016
Q3 | $18.2M | Buy |
482,458
+102,164
| +27% | +$3.85M | 0.09% | 231 |
|
|
2016
Q2 | $12.8M | Buy |
380,294
+10,420
| +3% | +$367K | 0.06% | 303 |
|
|
2016
Q1 | $11.8M | Buy |
369,874
+22,081
| +6% | +$721K | 0.06% | 336 |
|
|
2015
Q4 | $13M | Sell |
347,793
-12,911
| -4% | -$488K | 0.06% | 297 |
|
|
2015
Q3 | $13.7M | Sell |
360,704
-6,417
| -2% | -$225K | 0.07% | 283 |
|
|
2015
Q2 | $10.5M | Buy |
367,121
+2,467
| +0.7% | +$68.7K | 0.05% | 346 |
|
|
2015
Q1 | $10.2M | Buy |
364,654
+57,647
| +19% | +$1.62M | 0.05% | 338 |
|
|
2014
Q4 | $8.49M | Buy |
307,007
+27,329
| +10% | +$677K | 0.04% | 357 |
|
|
2014
Q3 | $6.24M | Buy |
279,678
+27,519
| +11% | +$699K | 0.03% | 430 |
|
|
2014
Q2 | $7.33M | Buy |
252,159
+27,933
| +12% | +$746K | 0.04% | 424 |
|
|
2014
Q1 | $6.37M | Buy |
224,226
+9,032
| +4% | +$299K | 0.03% | 478 |
|
|
2013
Q4 | $8.31M | Sell |
215,194
-5,643
| -3% | -$202K | 0.04% | 408 |
|
|
2013
Q3 | $7.4M | Sell |
220,837
-77,523
| -26% | -$2.47M | 0.04% | 411 |
|
|
2013
Q2 | $9.18M | Buy |
+298,360
| New | +$9.98M | 0.05% | 316 |
|
Other funds holding MDCO
Panagora Asset Management's MDCO Position: Q1 2020 in Review
Panagora Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 25,879 shares — an estimated $2.2M sold.
Panagora Asset Management first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $28.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Panagora Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Panagora Asset Management sold 25,879 Medicines Co shares in Q1 2020, an estimated $2.2M.
- Panagora Asset Management first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Panagora Asset Management's Medicines Co position peaked at $28.6M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Panagora Asset Management's 13F filing for Q1 2020, filed 14 May 2020.